RNAi 技术市场（按应用、最终用户和地区划分）

2025 年全球 RNAi 技术市场规模估计为 31.1 亿美元，预计到 2032 年将达到 82.7 亿美元，2025 年至 2032 年的复合年增长率为 15.0%。

数字。 2025 年 RNAi 技术市场占有率（按地区划分）

全球 RNAi 技术市场的成长是由RNA干扰技术在治疗开发和研究中的不断扩大的应用所推动的。 RNA干扰或RNAi是指由短干扰RNA（siRNA）或微型RNA（miRNA）介导的基因静默过程。 RNAi 已成为选择性抑制基因表现和功能基因组学筛选的有力工具。 RNAi 透过定序特定的致病基因，在开发新型治疗方法方面具有巨大的潜力。安全有效的输送系统的开发将进一步促进基于 RNAi 的治疗方法的商业化。生物製药公司和政府组织对 RNAi 研究和开发进行了大量投资，形成了强大的产品平臺。

市场动态

全球 RNAi 技术市场的成长受到 RNAi 技术在整体治疗领域治疗开发中不断扩大的应用所推动。目前有几种针对代谢、心血管和神经退化性疾病的候选药物正在进行临床试验。强大的产品平臺和新型 RNAi 药物的问世增强了人们对该技术治疗潜力的乐观情绪。然而，RNAi 传递中的技术挑战和脱靶效应可能会阻碍市场成长。此外，建立研发基础设施和进行临床开发需要大量的资本投入也限制了许多小型公司的发展。透过脂质奈米颗粒、聚合物奈米颗粒和配体共轭分子等新型递送系统克服递送挑战的持续研究可能为市场成长提供机会。 RNAi 药物在后期临床试验中取得的良好临床结果可能为市场成长提供机会。

研究的主要特点

• 本报告对全球 RNAi 技术市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（以十亿美元计）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球 RNAi 技术市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球 RNAi 技术市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过全球 RNAi 技术市场分析中使用的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球 RNAI 技术市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球 RNAi 技术市场（按应用划分）（十亿美元）

• 介绍
• 药物研发
• 治疗
• 神经病学
• 肿瘤学
• 感染疾病
• 代谢紊乱
• 其他的
• 功能基因体学
• 其他的

6. 2020 年至 2032 年全球 RNAi 技术市场（按最终用户划分）（十亿美元）

• 介绍
• 製药和生物技术公司
• 学术研究所
• CRO 和 CMO
• 其他的

7. 2020 年至 2032 年全球 RNAi 技术市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• 公司简介
  • Alnylam Pharmaceuticals
  • OriGene Technologies, Inc.
  • Arrowhead Pharmaceuticals
  • Dicerna Pharmaceuticals
  • Silence Therapeutics
  • Ionis Pharmaceuticals
  • Merck & Co.
  • Qiagen NV
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina BIoTech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics
• 兴衰
• 一致的机会地图

第九章参考文献与调查方法

• 参考
• 调查方法

Global Rnai Technology Market is estimated to be valued at USD 3.11 Bn in 2025 and is expected to reach USD 8.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.0% from 2025 to 2032.

Figure. Rnai Technology Market Share (%), By Region 2025

Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene silencing mediated by short interfering RNAs (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The development of safe and effective delivery systems further contributes to the commercialization of RNAi-based therapies. Significant investments in RNAi research and development from biopharma companies and government organizations are resulting in a strong product pipeline.

Market Dynamics:

Global RNAi technology market growth is driven by increasing applications of RNAi technology for developing treatments across therapeutic areas. Several drug candidates targeting metabolic, cardiovascular and neurodegenerative disorders are currently under clinical trials. The strong product pipeline and entry of novel RNAi drugs are creating high optimism around the therapeutic potential of this technology. However, technical challenges in RNAi delivery and off-target effects can hamper the market growth. Moreover, requirement of high capital investments for building R&D infrastructure and clinical development deters many small companies. Ongoing research on overcoming the delivery challenges through novel delivery systems such as lipid nanoparticles, polymeric nanoparticles and ligand-conjugated molecules can offer market growth opportunities. Promising clinical outcomes of RNAi-based drugs in late-stage trials can offer market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global RNAi technology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global RNAi technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Mirna Therapeutics, and Quark Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global RNAi technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global RNAi technology market

Detailed Segmentation-

• By Application
  • Drug Discovery and Development
  • Therapeutics
  • Neurology
  • Oncology
  • Infectious Diseases
  • Metabolic Diseases
  • Others
  • Functional Genomics
  • Other
• By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Alnylam Pharmaceuticals
  • OriGene Technologies, Inc.
  • Arrowhead Pharmaceuticals
  • Dicerna Pharmaceuticals
  • Silence Therapeutics
  • Ionis Pharmaceuticals
  • Merck & Co.
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina Biotech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Rnai Technology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global RNAi Technology Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Drug Discovery and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
• Oncology
• Infectious Diseases
• Metabolic Diseases
• Others
• Functional Genomics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global RNAi Technology Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CROs & CMOs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global RNAi Technology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Alnylam Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OriGene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arrowhead Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dicerna Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Silence Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ionis Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina Biotech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact